» Articles » PMID: 15852053

Pharmacogenomics Education: International Society of Pharmacogenomics Recommendations for Medical, Pharmaceutical, and Health Schools Deans of Education

Overview
Date 2005 Apr 27
PMID 15852053
Citations 43
Authors
Affiliations
Soon will be listed here.
Abstract

Pharmacogenomics would be instrumental for the realization of personalized medicine in coming decades. Efforts are evident to clarify the potential bioethical, societal, and legal implications of key pharmacogenomics-based technologies projected to be soon introduced into the core practice of medicine. In sharp contrast, a lack of sufficient attention to educational aspects of pharmacogenomics, both for professionals and for society at large, is evident. In order to contribute to this discussion, a 'Pharmacogenomics Education Forum' was held on October 2, 2004 during the 3rd Annual Meeting of the International Society of Pharmacogenomics (ISP) at Santorini, Greece. The participants, members of the ISP Pharmacogenomics Education Forum, after deliberate discussions, proposed a document of 'Background Statement' and 'Recommendations and Call for Action' addressed to Deans of Education at Medical, Pharmaceutical, and Health Schools globally. This document has been considered by the education committee of the International Society of Pharmacogenomics and the result is presented here. We hope that this call would be listened to, and soon followed by beneficial action, ultimately leading to enhanced implementation of personalized medicine into core medical education and practice.

Citing Articles

Analysis of the current situation of pharmacogenomics in terms of educational and healthcare needs in Egypt and Lebanon.

El-Gowilly S, Metwaly H, Makhlouf D, Elmansoury N, Abuiessa S, Sorour A Pharmacogenomics. 2024; 25(10-11):429-440.

PMID: 39382016 PMC: 11492645. DOI: 10.1080/14622416.2024.2403967.


Forging the path to precision medicine in Qatar: a public health perspective on pharmacogenomics initiatives.

Bastaki K, Velayutham D, Irfan A, Adnan M, Mohammed S, Mbarek H Front Public Health. 2024; 12:1364221.

PMID: 38550311 PMC: 10977610. DOI: 10.3389/fpubh.2024.1364221.


Estimating the efficacy of pharmacogenomics over a lifetime.

Ye Z, Mayer J, Leary E, Kitchner T, Dart R, Brilliant M Front Med (Lausanne). 2023; 10:1006743.

PMID: 38020121 PMC: 10645151. DOI: 10.3389/fmed.2023.1006743.


Pharmacogenomics in clinical trials: an overview.

Nogueiras-Alvarez R Front Pharmacol. 2023; 14:1247088.

PMID: 37927590 PMC: 10625420. DOI: 10.3389/fphar.2023.1247088.


Toward Integration of Pharmacogenomic Tests into Daily Clinical Practice: A General Survey for Polish Healthcare Workers.

Tafazoli A, Golinska A, Mnich K, Amirabadizadeh A, Clark Marquez J, Miltyk W Med Sci Monit. 2023; 29:e940119.

PMID: 37303136 PMC: 10274214. DOI: 10.12659/MSM.940119.